Literature DB >> 12871957

Kinetic analysis of platelet-derived growth factor receptor/phosphoinositide 3-kinase/Akt signaling in fibroblasts.

Chang Shin Park1, Ian C Schneider, Jason M Haugh.   

Abstract

Isoforms of the serine-threonine kinase Akt coordinate multiple cell survival pathways in response to stimuli such as platelet-derived growth factor (PDGF). Activation of Akt is a multistep process, which relies on the production of 3'-phosphorylated phosphoinositide (PI) lipids by PI 3-kinases. To quantitatively assess the kinetics of PDGF receptor/PI 3-kinase/Akt signaling in fibroblasts, a systematic study of this pathway was performed, and a mechanistic mathematical model that describes its operation was formulated. We find that PDGF receptor phosphorylation exhibits positive cooperativity with respect to PDGF concentration, and its kinetics are quantitatively consistent with a mechanism in which receptor dimerization is initially mediated by the association of two 1:1 PDGF/PDGF receptor complexes. Receptor phosphorylation is transient at high concentrations of PDGF, consistent with the loss of activated receptors upon endocytosis. By comparison, Akt activation responds to lower PDGF concentrations and exhibits more sustained kinetics. Further analysis and modeling suggest that the pathway is saturated at the level of PI 3-kinase activation, and that the p110alpha catalytic subunit of PI 3-kinase contributes most to PDGF-stimulated 3'-PI production. Thus, at high concentrations of PDGF the kinetics of 3'-PI production are limited by the turnover rate of these lipids, while the Akt response is additionally influenced by the rate of Akt deactivation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871957     DOI: 10.1074/jbc.M304968200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Spatial analysis of 3' phosphoinositide signaling in living fibroblasts: II. Parameter estimates for individual cells from experiments.

Authors:  Ian C Schneider; Jason M Haugh
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

2.  Spatial analysis of 3' phosphoinositide signaling in living fibroblasts: I. Uniform stimulation model and bounds on dimensionless groups.

Authors:  Jason M Haugh; Ian C Schneider
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

3.  Quantitative models of signal transduction networks: How detailed should they be?

Authors:  Murat Cirit; Jason M Haugh
Journal:  Commun Integr Biol       Date:  2011-05

4.  Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Authors:  Wan Hua Tan; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

5.  Quantitative model of Ras-phosphoinositide 3-kinase signalling cross-talk based on co-operative molecular assembly.

Authors:  Harjeet Kaur; Chang Shin Park; Jodee M Lewis; Jason M Haugh
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

6.  Deterministic model of dermal wound invasion incorporating receptor-mediated signal transduction and spatial gradient sensing.

Authors:  Jason M Haugh
Journal:  Biophys J       Date:  2006-01-13       Impact factor: 4.033

7.  Mathematical models of the VEGF receptor and its role in cancer therapy.

Authors:  Tomás Alarcón; Karen M Page
Journal:  J R Soc Interface       Date:  2007-04-22       Impact factor: 4.118

8.  Membrane-binding/modification model of signaling protein activation and analysis of its control by cell morphology.

Authors:  Jason M Haugh
Journal:  Biophys J       Date:  2007-04-06       Impact factor: 4.033

9.  Computational models of tandem SRC homology 2 domain interactions and application to phosphoinositide 3-kinase.

Authors:  Dipak Barua; James R Faeder; Jason M Haugh
Journal:  J Biol Chem       Date:  2008-01-20       Impact factor: 5.157

10.  Cell population-based model of dermal wound invasion with heterogeneous intracellular signaling properties.

Authors:  Michael I Monine; Jason M Haugh
Journal:  Cell Adh Migr       Date:  2008-04-26       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.